[Convenience Store] Retailers urged to remove unlisted CBD products from sale
[Cannabis Wealth] Authorised UK CBD products expected by 2023
The list of credible CBD products is now “one step closer to being authorised” as the FSA announces the next steps in regulating the UK CBD market.
[Cannabis Health] What the FSA Novel Food list means for UK CBD consumers
The FSA has today published its anticipated list of credible Novel Food applications, but what do you need to know as a CBD consumer in the UK?
[Cannabis Science and Technology] A New Commission Formed in the United Kingdom Plans to Publish Recommendations on How the UK Can Become a Global Leader in Cannabinoid Innovation
A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale.
[Nutra Ingredients] New commission to review the UK’s legal cannabis industry
A new commission has been set up by The Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI) and First November Group to review the legal cannabis industry in the UK.
[Analytical Cannabis] UK Commission Launched to Review Cannabinoid Policies
Some of the UK’s leading cannabinoid industry groups have announced a new commission to review the regulations and policies relating to the country’s legal cannabis industry.
[Whole Foods Magazine] U.K. Set to Release List of CBD Products Permitted for Sale
“The FSA has put in a tremendous amount of work to assess the many applications made, including the super-dossier submitted by ACI on behalf of our members,” said Steve Moore, Founder of ACI.
[Nutrition Insight] UK hemp and CBD industry on track for international market dominance, argues ACI
ACI rejects concerns over the future of the UK’s hemp industry after alliances accused a recent government CBD report of excluding crop producers in favour of pharmaceutical and research laboratory businesses.
[Nutra Ingredients] CBD companies told to provide sufficient toxicology data or risk losing product selling rights
Up to 40 CBD (cannabinoid) companies have been contacted by the UK Food Standards Agency (FSA) and told they have until 28 February to provide sufficient toxicology data or risk their products being removed from sale.
[Canex] Sector eagerly awaits publication of FSA’s list of approved CBD products
Participants in the UK’s CBD sector are on stand-by as they await the long-anticipated publication of the Food Standards Agency’s (FSA) list of approved CBD products. The list represents the biggest shake-up to date in the still-young industry.
